US17240Y1091 - Common Stock
CINCOR PHARMA INC
NASDAQ:CINC (2/23/2023, 7:00:00 PM)
After market: 29.25 +0.19 (+0.65%)29.06
-0.14 (-0.48%)
CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The company is headquartered in Waltham, Massachusetts and currently employs 19 full-time employees. The company went IPO on 2022-01-07. The firm is focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. CIN-107 is a highly selective, oral small molecule inhibitor of aldosterone synthase, the enzyme responsible for the synthesis of aldosterone in the adrenal gland. CIN-107 has been designed to use a differentiated mechanism of action, direct inhibition of aldosterone synthase production, with the target of providing an improved treatment for patients suffering from hypertension, or high blood pressure. In addition to hypertension, the Company is developing CIN-107 for the treatment of primary aldosteronism (PA) and exploring its utility in ameliorating complications of chronic kidney disease (CKD). The company also exploring its utility in ameliorating complications of CKD. The company is conducting a Phase II clinical trial, which it refers to as its BrigHtn trial.
CINCOR PHARMA INC
230 Third Ave., 6Th Floor
Waltham MASSACHUSETTS
P: 18445311834.0
Employees: 19
Website: https://www.cincor.com/
WALTHAM, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor” or the “Company”) announced today completion of an End-of-Phase 2 meeting...
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
Here you can normally see the latest stock twits on CINC, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: